Analyst Rating In Review: Novo Nordisk Sold Off 0.8% Since Upgraded 7 Days Ago (NVO)

One week ago Novo Nordisk (NYSE:NVO) was upgraded from Hold to Buy at Deutsche Bank. Novo Nordisk shares are selling at $45.73, 0.8% below the $46.10 price point of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.